On the other hand, mutations in UBQLN2, ATXN3, and TIA1 indicate a gain of function mechanism in C. elegans models of ALS (Fardghassemi et al., 2017; Andrusiak et al., 2019; Saxton and Kraemer, 2021). This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.